Effector Therapeutics Inc (EFTR) — Working Capital to Net Assets Ratio
Effector Therapeutics Inc (EFTR) has a Working Capital to Net Assets ratio of 82.3% as of March 2024. Working capital of $681.00K (current assets of $26.25 Million minus current liabilities of $25.57 Million) is measured against net assets of $827.00K. A higher ratio indicates strong short-term liquidity financed by the equity base. See Effector Therapeutics Inc net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Effector Therapeutics Inc Working Capital to Net Assets (2019–2023)
This chart shows how Effector Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2019 to 2023. As of March 2024, the ratio stands at 82.3%, reflecting working capital of $681.00K against net assets of $827.00K USD. Check Effector Therapeutics Inc (EFTR) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Effector Therapeutics Inc (2019–2023)
The table below presents the year-by-year Working Capital to Net Assets ratio for Effector Therapeutics Inc from 2019 to 2023, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Effector Therapeutics Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 102.8% | $-5.96 Million | $-5.79 Million | $19.84 Million | $25.80 Million | ▲ +27.4 pp |
| 2022 | 75.4% | $2.94 Million | $3.90 Million | $28.01 Million | $25.07 Million | ▼ -207.6 pp |
| 2021 | 283.0% | $48.92 Million | $17.28 Million | $52.90 Million | $3.98 Million | ▲ +288.9 pp |
| 2020 | -5.9% | $7.80 Million | $-132.25 Million | $16.58 Million | $8.78 Million | ▼ -111.8 pp |
| 2019 | 105.9% | $-14.66 Million | $-13.84 Million | $4.27 Million | $18.93 Million | — |